周二晚些时候,Diffusion宣布股东批准了合并。该公司还计划在上市前进行1比1.5的反向拆股,以符合纳斯达克的上市要求。合并后公司的股票原定于8月17日开始交易。
美股滚雪球2023-08-16 09:53
$Diffusion制药(DFFN)$ 股东投票通过了该公司与EIP Pharma的合并。预计将于8月16日结束。该公司还表示,股东们同意1比1.5的反向拆股方案。新公司将被命名为CervoMed,从8月17日开始,股票代码为“CRVO”
$贝达药业(SZ300558)$ $通策医疗(SH600763)$查看全文
美股滚雪球2023-03-31 09:57
$Diffusion制药(DFFN)$ 宣布与私人持有的EIP Pharma进行全股票合并。合并后的公司预计将更名为CervoMed,并以新的股票代码CRVO进行交易。该公司将专注于推进EIP Pharma的主要药物产品neflamabimod,该药物正在开发中,用于治疗路易体痴呆症(DLB)。
合并后的公司将继续在纳斯达克资本市场以新...查看全文
$Diffusion制药(DFFN)$ S-1 - General form for registration of securities under the Securities Act of 1933 Filed: 2017-12-20 AccNo: 0001437749-17-020965 Size: 568 KB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2017-11-20 AccNo: 0001437749-17-019579 Size: 17 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2017-11-13 AccNo: 0001437749-17-019013 Size: 162 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Diffusion制药(DFFN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-13 AccNo: 0001437749-17-019012 Size: 4 MB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2017-11-02 AccNo: 0001437749-17-018169 Size: 47 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.07: Submission of Matters to a Vote of Security HoldersItem 9.01: Financial Statements...
$Diffusion制药(DFFN)$ DEF 14A - Other definitive proxy statements Filed: 2017-09-18 AccNo: 0001437749-17-016021 Size: 597 KB 网页链接
$Diffusion制药(DFFN)$ PRE 14A - Other preliminary proxy statements Filed: 2017-09-08 AccNo: 0001437749-17-015800 Size: 683 KB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2017-08-14 AccNo: 0001437749-17-014722 Size: 266 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Diffusion制药(DFFN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-08-14 AccNo: 0001437749-17-014712 Size: 4 MB 网页链接
$Diffusion制药(DFFN)$ 8-K - Current report Filed: 2017-08-14 AccNo: 0001437749-17-014722 Size: 266 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接